https://www.accessnow.org:443/announcing-the-2014-access-facebook-award/

Announcing the 2014 Access Facebook Award

Access Innovation Prize Header

Access is pleased to announce the next round of the Access Facebook Award, part of the Access Innovation Prize. The Access Facebook Award seeks innovative projects using the Facebook platform to promote human rights and development, including tools that enhance freedom of speech and expression or improve the economic well-being of disadvantaged groups. We are looking for initiatives from around the world, in all languages and addressing issues that are important to you and your community.

The Access Facebook Award is designed to discover and reward projects that demonstrate unique promise, opportunity and possibility. Criteria and application instructions are listed on the Access Facebook Award webpage. The winner of the award will be announced at RightsCon: Silicon Valley in March.

Important Information

Sponsor a Prize

Thanks to Facebook for once again sponsoring the Access Innovation Prizes this year. Contact us at prize@accessnow.org to inquire about sponsoring a prize category and learn more about how you can help play an integral role in encouraging and supporting innovation designed to protect human rights.

We are excited to be able to provide this opportunity again this year, and would like to thank everyone who participated in the previous Access Facebook Award, including the judges, finalists, and winners. Access is proud to have brought together such an amazing set of people, and we look forward to doing it again this year!

Interested in the Endpoint Security Award?

In addition to the Access Facebook Award, Access is awarding US$50,000 to the project that best addresses the issue of improving “endpoint security” of individuals and communities working in high-risk environments. To find out more, visit the 2014 Access Innovation Prize page.

 

Help keep the internet open and secure

Subscribe to our action alerts and weekly newsletter

Your info is secure with us.